EcoDrugPlus

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSJJAG00000012713
Gene Symbol: HSD11B1
3 Cross references
248 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSJJAG00000012432
Gene Symbol: HCN4
3 Cross references
287 Possible Orthologues:

Hypocretin Receptor 1

Ensembl ID : ENSJJAG00000024301
Gene Symbol: HCRTR1
3 Cross references
96 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSJJAG00000010947
Gene Symbol: HCRTR2
3 Cross references
202 Possible Orthologues:

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSJJAG00000012421
Gene Symbol: IDO1
3 Cross references
98 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSJJAG00000010897
Gene Symbol: IMPDH1
3 Cross references
333 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSJJAG00000023299
Gene Symbol: IMPDH2
3 Cross references
200 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSJJAG00000022473
Gene Symbol: INPP5D
3 Cross references
213 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSJJAG00000012323
Gene Symbol: IGF1R
3 Cross references
274 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSJJAG00000023697
Gene Symbol: INSR
3 Cross references
288 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSJJAG00000018679
Gene Symbol: ITGA2B
3 Cross references
189 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSJJAG00000021734
Gene Symbol: ITGA4
3 Cross references
236 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).